DOCSLIB.ORG

Tratamiento En Medicina Tradicional China De COVID-19

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tratamiento En Medicina Tradicional China De COVID-19 Tratamiento en Medicina Tradicional China de COVID-19 Investigación y Evidencia Científica, Recopilación de Noticias y Guías https://www.catedrachina.com | https://fundacion.mtc.es | https://www.fundaciontn.es Autores Dr. Ramon Maria Calduch. Vicepresidente de Xinyue Calduch. Miembro del Executive Comité de Cátedra China. Vicepresidente de la Fundación European TCM. Directora de Relaciones Europea de MTC (FEMTC). Vicepresidente de Institucionales de la FEMTC. CEO de la ESMTC Fundación Terapias Naturales (FTN). Vice Más info de Xinyue Calduch en: Presidente de WFAS. Head of Delegation del https://www.linkedin.com/in/xinyue-calduch- ISO/TC249 750380103/ Más info de Ramón Mª Calduch en: www.ramonmariacalduch.com Dr. Mónica García. Coordinadora del Comité Mireia Masip. Secretaria General del Observatorio Científico del Observatorio de MTC-Acupuntura de de MTC-Acupuntura de FTN y Profesora de la FTN y Profesora de la FEMTC y Escuela Superior de FEMTC y ESMTC Medicina Tradicional China (ESMTC) Más info de Mireia Masip en: Más info de Mónica García en: https://www.linkedin.com/in/mireia-masip-sales/ https://www.esmtc.es/prof-monica-garcia.php Tratamiento en Medicina Tradicional China de COVID-19 | Fundación Europea de MTC 1 Contenido INTRODUCCIÓN .......................................................................................................................... 2 INVESTIGACIÓN Y EVIDENCIA CIENTÍFICA .................................................................................. 4 ARTICULOS .............................................................................................................................. 4 REFERENCIAS EN WEBS .......................................................................................................... 7 RECOPILACIÓN DE NOTICIAS ...................................................................................................... 8 GUÍAS ........................................................................................................................................11 ESTADOS UNIDOS .................................................................................................................11 R.P.CHINA .............................................................................................................................11 ESPAÑA .................................................................................................................................11 Anexo I: ARTÍCULOS INVESTIGACIÓN Y EVIDENCIA CIENTÍFICA (COMPLETOS O ABSTRACTS) 12 Tratamiento en Medicina Tradicional China de COVID-19 | Fundación Europea de MTC 1 INTRODUCCIÓN Los datos epidemiológicos existentes indican que el COVID-19 es un brote altamente transmisible de coronavirus. Es probable que la batalla con COVID-19 continúe durante meses a nivel mundial. Por lo tanto, se necesitan más estrategias además de la contención y la mitigación para su llegada a cualquier zona, especialmente aquellos países con infraestructura de salud poco desarrollada, para acortar la estancia hospitalaria y reducir el consumo de recursos sanitarios (Organización Mundial de la Salud, 2020a). En la actualidad, el COVID-19, al ser un virus recientemente identificado, tiene opciones de tratamiento farmacológico limitadas. La Medicina Tradicional China tiene un buen potencial para complementar las necesidades existentes, pudiendo ser una buena opción adicional considerando las opciones limitadas disponibles para COVID-19 (Chan et al, 2020). En China, la Medicina China se propone como una opción de tratamiento de alto uso según las directrices nacionales y provinciales. Se revisaron las últimas guías clínicas nacionales y provinciales, estudios de cohorte retrospectivos, series de casos sobre el tratamiento de COVID- 19 con la Medicina China como tratamiento complementario, entre otros. Los datos disponibles sugieren que Medicina China podría considerarse como una opción terapéutica complementaria en el tratamiento de COVID-19. La estrategia debe enfocarse en ir al origen del problema para acortar la duración de la fiebre, aliviar los síntomas, prevenir la progresión de la enfermedad, reducir la mortalidad y ayudar a la recuperación. La evidencia actual indica que la MTC tiene un beneficio potencial en el alivio sintomático, acortando la duración de la fiebre, revertiendo los cambios radiológicos y acortando la estancia hospitalaria (Lu et al., 2020a; Xia et al., 2020; Yao et al., 2020). Para el tratamiento del COVID-19 con MTC, la directriz nacional estableció varios periodos; el periodo de observación médica, el período de tratamiento (leve, intermedio, grave y crítico) y el periodo de recuperación. En cada periodo y fase se recomiendan fórmulas fitoterapéuticas de Medicina china y acupuntura. Las directrices provinciales se optimizaron en función de las directrices nacionales para la adaptación local, la mayoría involucraban medidas preventivas y de tratamiento de Medicina china (Chen et al., 2020b; Pang et al., 2020; Zheng et al., 2020). La utilización de la Medicina china en la gestión del COVID-19 ha sido muy significativa en China (Gao et al., 2020). Los casos confirmados de COVID-19 en Shanghai comenzaron el tratamiento integral de Medicina China y la Medicina Occidental (Yuan et Qiu, 2020). En Guangdong, los gránulos de Tou-jie-qu-wen (neumonía n.°1) se evaluaron con una serie de casos y se recomendaron a 30 hospitales designados como el tratamiento estándar de los pacientes con COVID-19 (Administración de Productos Médicos de Guangdong, 2020). En general, más del 85% de los casos confirmados involucraron el uso de MTC a nivel nacional (Wuhan más del 67%) (Le y Liang, 2020; El Consejo de Estado, la República Popular de China, 2020b) y el primer Hospital Módulo designado orientado a MTC en Wuhan funcionó desde el 14 de febrero de 2020 (Wang y Li, 2020). Son varios los estudios puestos en marcha, a partir del 22 de febrero de 2020, había tres cohortes retrospectivas (Lu et al., 2020a; Xia et al., 2020; Yao et al., 2020), cinco series de casos (Cheng y Li, 2020; Dai et al., 2020 ; Administración de Productos Médicos de Guangdong, 2020; Administración Nacional de Medicina Tradicional China, 2020b; Yong et al., 2020), y dos estudios de caso (Hu et al., 2020; Sun et al., 2020b) sobre la gestión integrada con Medicina China y Medicina Occidental del COVID -19. A partir del 22 de febrero de 2020, se registraron 24 y 141 estudios de intervención relacionados con COVID- 19 en ClinicalTrials.gov y Chinese Clinical Trial Registry, respectivamente, incluyendo la Medicina China. De los 53 ensayos clínicos relacionados con Medicina China, 27 ensayos evalúan los programas de Medicina China y tratamiento integrado. Tratamiento en Medicina Tradicional China de COVID-19 | Fundación Europea de MTC 2 La acupuntura y moxibustión juegan un papel activo en la prevención y el tratamiento de enfermedades infecciosas, habiendo participado activamente frente al COVID-19, en la prevención y el control, logrando buenos resultados, y estableciéndose las Directrices sobre Intervención de Acupuntura y Moxibustión para el COVID-19 (Guidelines on Acupuncture and Moxibustion Intervention for COVID-19 (second edition)). En la lucha contra la pandemia de neumonía causada por la infección del COVID-19, el Hospital Provincial de Medicina Tradicional China de Hubei utilizó diligentemente las especialidades de la Medicina China, en cooperación con los departamentos pertinentes para estudiar y formular programas de prevención y tratamiento de la neumonía, estableciendo protocolos de acupuntura y moxibustión para la prevención y el tratamiento del coronavirus. Se puso de manifiesto que la fitoterapia china jugó un papel importante en los resultados positivos del tratamiento. Las fórmulas herbales chinas albergan el potencial único de reducir los síntomas de la fiebre y la tos, limitar la progresión de la enfermedad y mejorar la inmunidad general y, por lo tanto, la capacidad de una persona de generar una respuesta inmune esencial al virus, debiéndose integrar en un plan de tratamiento integral que utilice tanto la medicina occidental como la china para garantizar resultados óptimos para el paciente. Los resultados de la colaboración entre la medicina occidental y la china en Wuhan han sido muy prometedores (Chen et al., 2020). Son varias las Guías publicadas en China sobre la MTC y el COVID19 y varias las noticias que resaltan los buenos resultados gracias a la integración de la Medicina China y la Medicina Occidental para hacer frente al COVID- 19. Una de estas noticias más recientes expone las declaraciones de Yu Yanhong, portavoz del Ministerio de Sanidad Chino y también subdirector de la Administración Nacional de Tradicional Medicina china, indicando que el método puede mejorar rápidamente la condición de los pacientes con síntomas leves, como fiebre, tos, dolor de garganta, debilidad y falta de apetito, también puede ayudar a reducir la duración de la estancia en el hospital. Los expertos chinos señalan buenos resultados de la combinación de medicina china y occidental para el coronavirus y encuentran que la combinación puede ayudar a prevenir el desarrollo de síntomas leves en condiciones graves y críticas, lo que reduce la tasa de mortalidad de la enfermedad. Desde el brote de Covid-19, las autoridades centrales chinas han destacado en muchas ocasiones la aplicación de la medicina tradicional china combinada con la medicina occidental en el tratamiento de pacientes. Según la Administración Nacional de TMTC, los equipos de expertos médicos en 31 regiones
Load more

Recommended publications
  • Cornus Canadensis Serge Lavoie, Isabelle Côté, André Pichette, Charles Gauthier, Michaël Ouellet, Francine Nagau-Lavoie, Vakhtang Mshvildadze, Jean Legault
    Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis Serge Lavoie, Isabelle Côté, André Pichette, Charles Gauthier, Michaël Ouellet, Francine Nagau-Lavoie, Vakhtang Mshvildadze, Jean Legault To cite this version: Serge Lavoie, Isabelle Côté, André Pichette, Charles Gauthier, Michaël Ouellet, et al.. Chem- ical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis. BMC Complementary and Alternative Medicine, BioMed Central, 2017, 17 (1), pp.123. 10.1186/s12906-017-1618-2. pasteur-01534565 HAL Id: pasteur-01534565 https://hal-riip.archives-ouvertes.fr/pasteur-01534565 Submitted on 7 Jun 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike| 4.0 International License Lavoie et al. BMC Complementary and Alternative Medicine (2017) 17:123 DOI 10.1186/s12906-017-1618-2 RESEARCH ARTICLE Open Access Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis Serge Lavoie1, Isabelle Côté1, André Pichette1, Charles Gauthier1,2, Michaël Ouellet1, Francine Nagau-Lavoie1, Vakhtang Mshvildadze1 and Jean Legault1* Abstract Background: Many plants of boreal forest of Quebec have been used by Native Americans to treat a variety of microbial infections.
    [Show full text]
  • Policy Disparities in Response to the First Wave of COVID-19 Between China and Germany Yuyao Zhang1, Leiyu Shi2, Haiqian Chen1, Xiaohan Wang1 and Gang Sun1,2*
    Zhang et al. International Journal for Equity in Health (2021) 20:86 https://doi.org/10.1186/s12939-021-01424-3 RESEARCH Open Access Policy disparities in response to the first wave of COVID-19 between China and Germany Yuyao Zhang1, Leiyu Shi2, Haiqian Chen1, Xiaohan Wang1 and Gang Sun1,2* Abstract Objective: Our research summarized policy disparities in response to the first wave of COVID-19 between China and Germany. We look forward to providing policy experience for other countries still in severe epidemics. Methods: We analyzed data provided by National Health Commission of the People’s Republic of China and Johns Hopkins University Coronavirus Resource Center for the period 10 January 2020 to 25 May 252,020. We used generalized linear model to evaluate the associations between the main control policies and the number of confirmed cases and the policy disparities in response to the first wave of COVID-19 between China and Germany. Results: The generalized linear models show that the following factors influence the cumulative number of confirmed cases in China: the Joint Prevention and Control Mechanism; locking down the worst-hit areas; the highest level response to public health emergencies; the expansion of medical insurance coverage to suspected patients; makeshift hospitals; residential closed management; counterpart assistance. The following factors influence the cumulative number of confirmed cases in Germany: the Novel Coronavirus Crisis Command; large gathering cancelled; real-time COVID-19 risk assessment; the medical emergency plan; schools closure; restrictions on the import of overseas epidemics; the no-contact protocol. Conclusions: There are two differences between China and Germany in non-pharmaceutical interventions: China adopted the blocking strategy, and Germany adopted the first mitigation and then blocking strategy; China’s goal is to eliminate the virus, and Germany’s goal is to protect high-risk groups to reduce losses.
    [Show full text]
  • Phytochemical Analysis and Antimicrobial Activity of Myrcia Tomentosa (Aubl.) DC
    molecules Article Phytochemical Analysis and Antimicrobial Activity of Myrcia tomentosa (Aubl.) DC. Leaves Fabyola Amaral da Silva Sa 1,3, Joelma Abadia Marciano de Paula 2, Pierre Alexandre dos Santos 3, Leandra de Almeida Ribeiro Oliveira 3, Gerlon de Almeida Ribeiro Oliveira 4, Luciano Morais Liao 4 , Jose Realino de Paula 3,* and Maria do Rosario Rodrigues Silva 1,* 1 Institute of Tropical Pathology and Public Health, Federal University of Goias, Goiânia 74605-050, Brazil; [email protected] 2 Unit of Exact and Technologic Sciences, Goias State University, Anápolis 75132-400, Brazil; [email protected] 3 Faculty of Pharmacy, Federal University of Goias, Goiânia 74605-170, Brazil; [email protected] (P.A.d.S.); [email protected] (L.d.A.R.O.) 4 Chemistry Institute, Federal University of Goiás, Goiânia 74690-900, Brazil; [email protected] (G.d.A.R.O.); [email protected] (L.M.L.) * Correspondence: [email protected] (J.R.d.P.); [email protected] (M.d.R.R.S.); Tel.: +55-62-3209-6127 (M.d.R.R.S.); Fax: +55-62-3209-6363 (M.d.R.R.S.) Academic Editor: Isabel C. F. R. Ferreira Received: 23 May 2017; Accepted: 29 June 2017; Published: 4 July 2017 Abstract: This work describes the isolation and structural elucidation of compounds from the leaves of Myrcia tomentosa (Aubl.) DC. (goiaba-brava) and evaluates the antimicrobial activity of the crude extract, fractions and isolated compounds against bacteria and fungi. Column chromatography was used to fractionate and purify the extract of the M. tomentosa leaves and the chemical structures of the compounds were determined using spectroscopic techniques.
    [Show full text]
  • Fighting Bisphenol A-Induced Male Infertility: the Power of Antioxidants
    antioxidants Review Fighting Bisphenol A-Induced Male Infertility: The Power of Antioxidants Joana Santiago 1 , Joana V. Silva 1,2,3 , Manuel A. S. Santos 1 and Margarida Fardilha 1,* 1 Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal; [email protected] (J.S.); [email protected] (J.V.S.); [email protected] (M.A.S.S.) 2 Institute for Innovation and Health Research (I3S), University of Porto, 4200-135 Porto, Portugal 3 Unit for Multidisciplinary Research in Biomedicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal * Correspondence: [email protected]; Tel.: +351-234-247-240 Abstract: Bisphenol A (BPA), a well-known endocrine disruptor present in epoxy resins and poly- carbonate plastics, negatively disturbs the male reproductive system affecting male fertility. In vivo studies showed that BPA exposure has deleterious effects on spermatogenesis by disturbing the hypothalamic–pituitary–gonadal axis and inducing oxidative stress in testis. This compound seems to disrupt hormone signalling even at low concentrations, modifying the levels of inhibin B, oestra- diol, and testosterone. The adverse effects on seminal parameters are mainly supported by studies based on urinary BPA concentration, showing a negative association between BPA levels and sperm concentration, motility, and sperm DNA damage. Recent studies explored potential approaches to treat or prevent BPA-induced testicular toxicity and male infertility. Since the effect of BPA on testicular cells and spermatozoa is associated with an increased production of reactive oxygen species, most of the pharmacological approaches are based on the use of natural or synthetic antioxidants.
    [Show full text]
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants
    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
    [Show full text]
  • Airborne SARS-Cov-2 and the Use of Masks for Protection Against Its Spread in Wuhan, China
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 29 May 2020 Airborne SARS-CoV-2 and the Use of Masks for Protection against Its Spread in Wuhan, China Jia Hu1#, Chengfeng Lei1#, Zhen Chen1#, Weihua Liu3#, Xujuan Hu3, Rongjuan Pei1, Zhengyuan Su1, Fei Deng1, Yu Huang2, Xiulian Sun1, Junji Cao2* Wuxiang Guan1* 1. Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, China 2. Key Lab of Aerosol Chemistry and Physics, SKLLQG, Institute of Earth Environment, Chinese Academy of Sciences, Xi’an, Shanxi, China 3. Wuhan Jinyintan Hospital, Wuhan, Hubei, China # Contributed equally to the work. *Corresponding authors: E-mail: WX Guan: [email protected], JJ Cao: [email protected] 1 © 2020 by the author(s). Distributed under a Creative Commons CC BY license. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 29 May 2020 Abstract: The outbreak of COVID-19 has caused a global public health crisis. The spread of SARS-CoV-2 by contact is widely accepted, but the relative importance of aerosol transmission for the spread of COVID-19 is controversial. Here we characterize the distribution of SARA-CoV-2 in 123 aerosol samples, 63 masks, and 30 surface samples collected at various locations in Wuhan, China. The positive percentages of viral RNA included 21% of the aerosol samples from an intensive care unit and 39% of the masks from patients with a range of conditions. A viable virus was isolated from the surgical mask of one critically ill patient while all viral RNA positive aerosol samples were cultured negative.
    [Show full text]
  • As Schools Reopen, Classes Discuss Battles Against Novel Coronavirus Epidemic and Floods by Ji Jing
    NATION: COVID-19 HEROES HONORED P.28 | BUSINESS: BEIJING FAIR’S GLOBAL SERVICE P.30 VOL.63 NO.38 SEPTEMBER 17, 2020 WWW.BJREVIEW.COM RAISING THE STANDARD Schools reopen with greater resilience RMB6.00 USD1.70 AUD3.00 GBP1.20 CAD2.60 CHF2.60 JPY188 邮发代号2-922·国内统一刊号：CN11-1576/G2 VOL.63 NO.38 SEPTEMBER 17, 2020 CONTENTS EDITOR’S DESK BUSINESS 02 A Fresh Start 34 New Offers Keen African interest in CIFTIS THIS WEEK 38 Emboldened by Independence China’s drone industry soars COVER STORY 40 Market Watch 16 A Noble Cause Teachers given their dues CULTURE 44 The Past Is the Future 18 Reshuffling an Industry Book puts Sino-U.S. ties in perspective COVID-19 changes after-class tuition structure 12 COVER STORY FORUM WORLD 46 Can Social Media Help the Young Overcome Their Social Phobia? 24 The United Nations’ Role Learning Life’s Lessons World body remains more New resolutions mark relevant today EXPAT’S EYE 26 The Tireless Bridge Builder school reopening 48 Life With Health Code Onslaught on Confucius Institute Zimbabwean student unravels mystery leaves pioneer unfazed of Suikang WORLD NATION P.22 | Remembering History’s Legacy 28 People’s Heroes Nation salutes extraordinary citizens Anti-fascist victory demonstrates power of East-West cooperation BUSINESS P.36 | New Free Trade Forces Report card on new FTZs’ progress BUSINESS Cover Photo: First graders attend class at Taipinglu Primary School in Beijing on August 29 (XINHUA) P.30 | Digital Dividends Trade fair shows innovations for ©2020 Beijing Review, all rights reserved. post-pandemic growth www.bjreview.com Follow us on MEDIA PARTNER BREAKING NEWS » SCAN ME » Using a QR code reader Beijing Review (ISSN 1000-9140) is published weekly for US$61.00 per year by Cypress Books, 360 Swift Avenue, Suite 48, South San Francisco, CA 94080, Periodical Postage Paid at South San Francisco, CA 94080.
    [Show full text]
  • Pursue Greater Unity and Progress News Brief
    VOL.50 ISSUE 3 · 2020 《中国人大》对外版 NPC National People’s Congress of China PURSUE GREATER UNITY AND pROGRESS NEWS BRIEF President Xi Jinping attends a video conference with United Nations Secretary-General António Guterres from Beijing on September 23. Liu Weibing 2 NATIONAL PEOPle’s CoNGRESS OF CHINA ISSUE 3 · 2020 3 6 Pursue greater unity and progress Contents UN’s 75th Anniversary CIFTIS: Global Services, Shared Prosperity National Medals and Honorary Titles 6 18 26 Pursue greater unity Global services, shared prosperity President Xi presents medals and progress to COVID-19 fighters 22 9 Shared progress and mutually Special Reports Make the world a better place beneficial cooperation for everyone 24 30 12 Accelerated development of trade in Work together to defeat COVID-19 Xi Jinping meets with UN services benefits the global economy and build a community with a shared Secretary-General António future for mankind Guterres 32 14 Promote peace and development China’s commitment to through parliamentary diplomacy multilateralism illustrated 4 NATIONAL PEOPle’s CoNGRESS OF CHINA 42 The final stretch Accelerated development of trade in 24 services benefits the global economy 36 Top legislator stresses soil protection ISSUE 3 · 2020 Fcous 38 Stop food waste with legislation, 34 crack down on eating shows Top legislature resolves HKSAR Leg- VOL.50 ISSUE 3 September 2020 Co vacancy concern Administrated by General Office of the Standing Poverty Alleviation Committee of National People’s Congress 36 Top legislator stresses soil protection Chief Editor: Wang Yang General Editorial 42 Office Address: 23 Xijiaominxiang, The final stretch Xicheng District, Beijing 37 100805, P.R.China Full implementation wildlife protection Tel: (86-10)5560-4181 law stressed (86-10)6309-8540 E-mail: [email protected] COVER: President Xi Jinping ad- ISSN 1674-3008 dresses a high-level meeting to CN 11-5683/D commemorate the 75th anniversary Price: RMB 35 of the United Nations via video link Edited by The People’s Congresses Journal on September 21.
    [Show full text]
  • Read More In
    Contents Abstract ......................................................................................................................... 2 Introduction .................................................................................................................. 3 I. Facing COVID-19 – the Common Enemy .............................................................. 4 II. Taking Measures Suitable to National Circumstances ........................................ 6 2.1 China’s Intensive Combat against COVID-19 ................................................. 6 2.2 The “Protracted War” in Europe ...................................................................... 8 III. Working Together to Fight the Common Enemy ............................................. 14 3.1 Building Confidence through Mutual Support .............................................. 14 3.2 Sharing Experience to Improve Patient Treatment ........................................ 19 3.3 Providing Supplies in the Spirit of Reciprocity ............................................. 23 IV. Building a Community of Shared Future .......................................................... 27 4.1 Overcoming Prejudices .................................................................................. 27 4.2 Protecting the Economy and People’s Livelihood ......................................... 34 4.3 Working Together to Advance Post-Pandemic Development ........................ 37 Conclusion .................................................................................................................
    [Show full text]
  • Emergency Architecture. Modular Construction of Healthcare Facilities As a Response to Pandemic Outbreak
    E3S Web of Conferences 274, 01013 (2021) https://doi.org/10.1051/e3sconf/202127401013 STCCE – 2021 Emergency architecture. Modular construction of healthcare facilities as a response to pandemic outbreak Marina Smolova1, and Daria Smolova2[0000-0002-2297-0505] 1Kazan State University of Architecture and Engineering, 420043 Kazan, Russia 2NFOE Inc., QC H2Y 2W7 Montreal, Canada Abstract. Emerging infectious diseases originating from wildlife species continue to demolish humankind leaving an imprint on human history. December 2019 has marked the emergence of a novel coronavirus named SARS-CoV-2 (Covid-2019) originated in China in the city of Wuhan. Drastic emergence and spread of infectious disease have shown to appear in highly densified areas causing rapid spread of epidemic through population movement, transmission routes, major activity nodes, proximity, and connectivity of urban spaces. An extreme number of cases rising throughout the world caused space unavailability in healthcare facilities to serve patients infected with Covid-2019, therefore urging for innovative emergency management response from construction and architecture industry. Prefabricated modular construction has been widely utilized around the globe assembling rapid response facilities after catastrophic events such as tornadoes, hurricanes, and forest fires. An increasing number of Covid-2019 cases demanded effective and compressed implementation of medical centres to provide expeditious and secure healthcare. The paper examines the potential of standardization of modular construction of hospitals as a response to current and potential pandemic outbreaks. The research provides fundamental planning requirements of isolation units and their design flexibility as a key to rapid emergency solution. Keywords. Modular construction, prefabrication, prefabricated construction, emergency architecture, healthcare facilities, hospitals, prefabricated architecture, Covid-2019.
    [Show full text]
  • Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19
    medRxiv preprint doi: https://doi.org/10.1101/2020.03.09.20033068; this version posted March 12, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19 Authors: Hua Fan1*;Lin Zhang1*;Bin Huang2*;Muxin Zhu3*;Yong Zhou3*;Huan Zhang1;Xiaogen Tao1;Shaohui Cheng1;Wenhu Yu4†;Liping Zhu3†;Jian Chen1† Affiliations: 1Department of Intensive Care Medicine,The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, China 2Department of Endocrinology,The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, China 3Infection Disease Department, Wuhan Jinyintan Hospital, Wuhan,Hubei,430023,China; 4Department of Intensive Care Medicine, Xiantao First People’s Hospital, Xiantao,Hubei,433000,China; Hua Fan ;Lin Zhang ;Bin Huang ; Muxin Zhu;Yong Zhou have contributed equally to this work *Contributed equally †Joint corresponding authors Corresponding Author: NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.03.09.20033068; this version posted March 12, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,399,783 B2 Rosenbloom (45) Date of Patent: Jul
    US007399.783B2 (12) United States Patent (10) Patent No.: US 7,399,783 B2 Rosenbloom (45) Date of Patent: Jul. 15, 2008 (54) METHODS FOR THE TREATMENT OF SCAR Quercetin: Implications for the Treatment of Excessive Scars.” TSSUE Internet Web Page, vol. 57(5); Nov. 2004. Marilyn Sterling, R.D., Article: Science Beat, Internet Web Page, (75) Inventor: Richard A. Rosenbloom, Elkins Park, Natural Foods Merchandiser vol. XXIV, No. 10, p. 50, 2003. PA (US) Phan TT. See P. Tran E. Nguyen TT, Chan SY. Lee ST and Huynh H., PubMed, Internet Web Page, “Suppression of Insulin-like Growth (73) Assignee: The Quigley Corporation, Doylestown, Factor Signalling Pathway and Collagen Expression in Keloid-De rived Fibroblasts by Quercetin: It's Therapeutic Potential Use in the PA (US) Treatment and/or Prevention of Keloids.” Br. J. Dermatol., Mar. 2003, 148(3):544-52. (*) Notice: Subject to any disclaimer, the term of this Crystal Smith, Kevin A. Lombard, Ellen B. Peffley and Weixin Liu; patent is extended or adjusted under 35 "Genetic Analysis of Quercetin in Onion (Allium cepa L.) Lady U.S.C. 154(b) by 440 days. Raider.” The Texas Journal of Agriculture and Natural Resource, vol. 16 pp. 24-28, 2003. (21) Appl. No.: 11/158,986 Skin Actives Scientific L.L.C., Internet Web Page, “Quercetin.” Quercetin by Skinactives, printed on Apr. 10, 2006. (22) Filed: Jun. 22, 2005 Saulis, Alexandrina S. M.D.; Mogford, Jon H. Ph.D.; Mustoe, Tho mas A., M.D., Plastic and Reconstructive Surgery, “Effect of (65) Prior Publication Data Mederma on Hypertrophic Scarring in the Rabbit Ear Model.” Jour US 2006/O293257 A1 Dec.
    [Show full text]